Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stanley J Goldsmith

Showing results (1-10 of 61) with videos related to

Pageof 7
Sort By:
Seminars in Nuclear Medicine|February 2, 2010
Radioimmunotherapy of lymphoma: Bexxar and ZevalinStanley J Goldsmith
Seminars in Nuclear Medicine|January 29, 2011
To ablate or not to ablate: issues and evidence involved in 131I ablation of residual thyroid tissue in patients with differentiated thyroid carcinomaStanley J Goldsmith
Future Oncology (London, England)|February 27, 2009
Update on nuclear medicine imaging of neuroendocrine tumorsStanley J Goldsmith
Molecular Imaging and Radionuclide Therapy|January 25, 2017
Radioactive Iodine Therapy of Differentiated Thyroid Carcinoma: Redesigning the ParadigmStanley J Goldsmith
Seminars in Nuclear Medicine|December 18, 2019
Targeted Radionuclide Therapy: A Historical and Personal ReviewStanley J Goldsmith
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 7, 2003
18F-FDG PET evaluation of the response to therapy for lymphoma and for breast, lung, and colorectal carcinomaLale Kostakoglu, Stanley J Goldsmith
Seminars in Nuclear Medicine|November 29, 2008
Clinically proven radiopharmaceuticals for infection imaging: mechanisms and applicationsStanley J Goldsmith, Shankar Vallabhajosula
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 22, 2004
PET in the assessment of therapy response in patients with carcinoma of the head and neck and of the esophagusLale Kostakoglu, Stanley J Goldsmith
Seminars in Nuclear Medicine|December 6, 2014
Multiple myeloma: 18F-FDG-PET/CT and diagnostic imagingJasna Mihailovic, Stanley J Goldsmith
Radiographics : a Review Publication of the Radiological Society of North America, Inc|March 18, 2003
Clinical role of FDG PET in evaluation of cancer patientsLale Kostakoglu, Harry Agress, Stanley J Goldsmith
Pageof 7

Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
Seminars in Nuclear Medicine|February 2, 2010
Radioimmunotherapy of lymphoma: Bexxar and ZevalinStanley J Goldsmith
Seminars in Nuclear Medicine|January 29, 2011
To ablate or not to ablate: issues and evidence involved in 131I ablation of residual thyroid tissue in patients with differentiated thyroid carcinomaStanley J Goldsmith
Future Oncology (London, England)|February 27, 2009
Update on nuclear medicine imaging of neuroendocrine tumorsStanley J Goldsmith
Molecular Imaging and Radionuclide Therapy|January 25, 2017
Radioactive Iodine Therapy of Differentiated Thyroid Carcinoma: Redesigning the ParadigmStanley J Goldsmith
Seminars in Nuclear Medicine|December 18, 2019
Targeted Radionuclide Therapy: A Historical and Personal ReviewStanley J Goldsmith
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 7, 2003
18F-FDG PET evaluation of the response to therapy for lymphoma and for breast, lung, and colorectal carcinomaLale Kostakoglu, Stanley J Goldsmith
Seminars in Nuclear Medicine|November 29, 2008
Clinically proven radiopharmaceuticals for infection imaging: mechanisms and applicationsStanley J Goldsmith, Shankar Vallabhajosula
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 22, 2004
PET in the assessment of therapy response in patients with carcinoma of the head and neck and of the esophagusLale Kostakoglu, Stanley J Goldsmith
Seminars in Nuclear Medicine|December 6, 2014
Multiple myeloma: 18F-FDG-PET/CT and diagnostic imagingJasna Mihailovic, Stanley J Goldsmith
Radiographics : a Review Publication of the Radiological Society of North America, Inc|March 18, 2003
Clinical role of FDG PET in evaluation of cancer patientsLale Kostakoglu, Harry Agress, Stanley J Goldsmith
Pageof 7